Responses
Regular and young investigator award abstracts
Immunotherapy toxicities
657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
